IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Department of Justice (DOJ),

and

PALANTIR TECHNOLOGIES INC.,
a private defense contractor headquartered in Denver, Colorado,

and

JOHN DOE CONTRACTING AGENCIES AND AFFILIATES,
whose names and identities are presently unknown,
  Defendants.

⸻

⸻ 

MEMORANDUM OF LAW RE: Implant-Induced Mast Cell Activation Syndrome (MCAS) and Foreseeability of Harm

⸻

I. INTRODUCTION

This memorandum addresses the substantial body of medical and scientific evidence establishing that biomedical implants — including breast implants, orthopedic devices, and dental prostheses — provoke chronic immune activation and mast cell–mediated pathology. Given the longstanding awareness of these risks, Defendant National Institute of Allergy and Infectious Diseases (NIAID) cannot plausibly claim ignorance regarding the foreseeable harms associated with widespread, multi-site implantation in the Plaintiff, Kellyn Clay.

⸻

II. BREAST IMPLANTS AS A WELL-ESTABLISHED MODEL OF IMMUNE DYSFUNCTION

Since the 1980s, silicone breast implants have been repeatedly associated with systemic immune disorders, chronic inflammation, and mast cell activation. Peer-reviewed literature documents symptoms overlapping with MCAS, including rashes, fatigue, flushing, idiopathic anaphylaxis, and connective tissue disorders. FDA labeling and litigation records acknowledge these risks.

⸻

III. ORTHOPEDIC AND RECONSTRUCTIVE IMPLANTS
	1.	Metal Hypersensitivity:
	•	Nickel, cobalt, chromium, and titanium alloys commonly used in plates, screws, and joint replacements are recognized immune sensitizers.
	•	Case reports and clinical studies describe “arthroplasty-related hypersensitivity,” characterized by skin eruptions, chronic pain, and systemic inflammatory sequelae.
	2.	Mast Cell Involvement:
	•	Studies show that mast cells accumulate around failing orthopedic implants, driving inflammation, fibrosis, and pain.
	•	These mast cell–mediated processes mirror the pathophysiology of MCAS.

⸻

IV. DENTAL IMPLANTS AND CRANIOFACIAL DEVICES

Titanium dental implants are associated with peri-implantitis, allergic reactions, and systemic immune dysregulation in sensitized patients. Mast cells are heavily implicated in peri-implant tissue breakdown, underscoring the broader connection between implants and immune activation.

⸻

V. AUTOIMMUNE / AUTOINFLAMMATORY SYNDROMES (ASIA)

The concept of Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) encompasses immune responses triggered by foreign bodies, including implants. Clinical manifestations overlap substantially with MCAS, further cementing the connection between implants and chronic mast cell–driven illness.

⸻

VI. FORESEEABILITY OF HARM TO PLAINTIFF

Given:
	•	Decades of literature linking breast implants to MCAS-like syndromes;
	•	Multiple categories of implants (orthopedic, dental, reconstructive) independently associated with hypersensitivity and mast cell–mediated pathology; and
	•	The acknowledged mast cell role in foreign-body responses;

It was entirely foreseeable that subjecting Plaintiff to distributed implants across organs and nerve sites would trigger severe, lifelong MCAS. NIAID, as the lead federal agency on allergy and immune disorders, possessed actual or constructive knowledge of these risks and failed to prevent or mitigate foreseeable harm.

⸻

VII. CONCLUSION

The record demonstrates that NIAID cannot disclaim knowledge of the implant–MCAS link. The harm to Plaintiff was not an unforeseeable aberration but an inevitable consequence of implanting foreign materials throughout the body.

Respectfully submitted,
Kellyn Clay, Plaintiff, pro se

